• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    3.43 Up 0.19(5.71%) Feb 12, 3:59PM EST
    Prev Close:3.24
    Open:3.32
    Bid:3.21 x 1000
    Ask:3.75 x 1000
    1y Target Est:10.91
    Beta:3.17254
    Next Earnings Date:25-Feb-16KERX Earnings announcement
    Day's Range:3.21 - 3.43
    52wk Range:2.80 - 14.89
    Volume:914,706
    Avg Vol (3m):1,644,350
    Market Cap:360.29M
    P/E (ttm):N/A
    EPS (ttm):-1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 5.71%360.29M
    BAXUp 2.03%20.03B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):40.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.03

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback